Campbell & Co Investment Adviser’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-84,454
| Closed | -$317K | – | 1275 |
|
|
2024
Q1 | $317K | Buy |
84,454
+44,839
| +113% | +$168K | 0.03% | 883 |
|
|
2023
Q4 | $389K | Sell |
39,615
-11,857
| -23% | -$116K | 0.04% | 825 |
|
|
2023
Q3 | $430K | Buy |
+51,472
| New | +$430K | 0.05% | 585 |
|
|
2022
Q2 | – | Sell |
-13,176
| Closed | -$120K | – | 860 |
|
|
2022
Q1 | $120K | Buy |
+13,176
| New | +$120K | 0.03% | 659 |
|
|
2021
Q3 | – | Sell |
-10,000
| Closed | -$350K | – | 721 |
|
|
2021
Q2 | $350K | Buy |
+10,000
| New | +$350K | 0.14% | 265 |
|